get a key
steadybase-$ company BCYC
account_id none on file
legal_name Bicycle Therapeutics PLC
ticker BCYC
cik 1761612
domain bicycletherapeutics.com
entry_point_account_id none on file
name Bicycle Therapeutics plc
exchange Nasdaq
sector Health Care
calls 0 filings 19 executives 3 family 0
why_nownone on file
callsnone on file
filings
accounting, auditing, tax and consulting services, insurance, travel expenses and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs.

filing / Jul 30, 2026 / receipt

Together, the workforce reduction and strategic reprioritization are expected to reduce our annual operating expenses by approximately 50% based on our current plans.

filing / Jul 30, 2026 / receipt

We expect the workforce reduction to be substantially completed by the end of 2026, and that we will incur aggregate charges of approximately $6.5 million, representing cash expenditure for severance and other employee termination benefits, of which $1.3 million and $5.5 million was recognized during the three and six months ended June 30, 2026, respectively.

filing / Jul 30, 2026 / receipt

We expect that our expenses and capital requirements will decrease in the near term as a result of our cost saving initiatives and our strategic reprioritization announced in March 2026.

filing / Jul 30, 2026 / receipt

We expect that our research and development expenses will decrease in the near term as a result of our cost saving initiatives and our strategic reprioritization announced in March 2026.

filing / Jul 30, 2026 / receipt

Further, because of our hybrid work environment, information that is normally protected, including company confidential information, may be less secure.

filing / Jul 30, 2026 / receipt

accounting, auditing, tax and consulting services, insurance, travel expenses and facility-related expenses, which include direct depreciation costs and allocated expenses for rent and maintenance of facilities and other operating costs.

filing / Apr 30, 2026 / receipt

Together, the workforce reduction and strategic reprioritization are expected to reduce our annual operating expenses by approximately 50% based on our current plans.

filing / Apr 30, 2026 / receipt

We expect the workforce reduction to be substantially completed by the end of 2026, and that we will incur aggregate charges, representing cash expenditure for severance and other employee termination benefits, of approximately $7.2 million, $4.2 million of which was recognized during the three months ended March 31, 2026.

filing / Apr 30, 2026 / receipt

We expect that our expenses and capital requirements will decrease in the near term as a result of our cost saving initiatives and our strategic reprioritization announced in March 2026.

filing / Apr 30, 2026 / receipt

We expect that our research and development expenses will decrease in the near term as a result of our cost saving initiatives and our strategic reprioritization announced in March 2026.

filing / Apr 30, 2026 / receipt

Further, because of our hybrid work environment, information that is normally protected, including company confidential information, may be less secure.

filing / Apr 30, 2026 / receipt

executives
Alethia Young Chief Financial Officer - receipt
Alistair Milnes Chief Corporate Development Officer - receipt
Travis Thompson Chief Accounting Officer (CAO) linkedin receipt
familynone on file
upcoming
2026-10-29 earnings call scheduled ir
changes
2026-02-03 Chief Financial Officer, appointed sec_8k
2023-06-23 Chief Accounting Officer, appointed sec_8k
2023-06-23 Chief Financial Officer, appointed sec_8k
2022-01-05 Chief Operating Officer, appointed sec_8k
mcp_package_hint
steadybase-$